Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ |
Upstream (Parents) |
---|
(<<) IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ |
(<<) IGKV4-1 → LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ |
(<<) IGJ → LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ |
Downstream (Children) |
---|
LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ (>>) |
LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → VCY1B///VCX3A///VCY (>>) |
LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → CRYBA2 (>>) |
LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → RHAG (>>) |
LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → KCNN3 (>>) |